SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,549,000 | +60.1% | 450,000 | +51.3% | 2.20% | +84.6% |
| Q2 2023 | $34,069,700 | -40.6% | 297,500 | -28.5% | 1.19% | -37.5% |
| Q1 2023 | $57,337,280 | -58.1% | 416,000 | -60.6% | 1.90% | -35.8% |
| Q4 2022 | $136,706,900 | +30.4% | 1,055,000 | +11.3% | 2.96% | +39.0% |
| Q3 2022 | $104,814,000 | +182.8% | 948,200 | +336.2% | 2.13% | +77.1% |
| Q4 2020 | $37,065,000 | +373.6% | 217,400 | +171.8% | 1.20% | +11.2% |
| Q1 2020 | $7,826,000 | – | 80,000 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |